BG61924B2 - Нови 3-циклоалкилпропанамиди,техни тавтомерни форми,техни соли,метод за получаването им,приложението им като лекарствени средства и съдържащите ги състави - Google Patents

Нови 3-циклоалкилпропанамиди,техни тавтомерни форми,техни соли,метод за получаването им,приложението им като лекарствени средства и съдържащите ги състави Download PDF

Info

Publication number
BG61924B2
BG61924B2 BG098526A BG9852694A BG61924B2 BG 61924 B2 BG61924 B2 BG 61924B2 BG 098526 A BG098526 A BG 098526A BG 9852694 A BG9852694 A BG 9852694A BG 61924 B2 BG61924 B2 BG 61924B2
Authority
BG
Bulgaria
Prior art keywords
formula
oxopropionitrile
hal
radical
cyclopropyl
Prior art date
Application number
BG098526A
Other languages
Bulgarian (bg)
English (en)
Inventor
Philip Hambelton
Charles John Hedgecock
David Kay
Anne Kuo
Wilfred Tully
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909023535A external-priority patent/GB9023535D0/en
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of BG61924B2 publication Critical patent/BG61924B2/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58—Radicals substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/24—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton
    • C07C255/27—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton containing cyano groups, amino groups and doubly-bound oxygen atoms bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/31—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
    • C07C255/60—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton at least one of the singly-bound nitrogen atoms being acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/40—Y being a hydrogen or a carbon atom
    • C07C323/41—Y being a hydrogen or an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BG098526A 1990-10-30 1994-02-23 Нови 3-циклоалкилпропанамиди,техни тавтомерни форми,техни соли,метод за получаването им,приложението им като лекарствени средства и съдържащите ги състави BG61924B2 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909023535A GB9023535D0 (en) 1990-10-30 1990-10-30 Chemical compounds
GB919105516A GB9105516D0 (en) 1990-10-30 1991-03-15 Chemical compounds

Publications (1)

Publication Number Publication Date
BG61924B2 true BG61924B2 (bg) 1998-09-30

Family

ID=26297867

Family Applications (1)

Application Number Title Priority Date Filing Date
BG098526A BG61924B2 (bg) 1990-10-30 1994-02-23 Нови 3-циклоалкилпропанамиди,техни тавтомерни форми,техни соли,метод за получаването им,приложението им като лекарствени средства и съдържащите ги състави

Country Status (25)

Country Link
US (2) US5240960B1 (cs)
EP (1) EP0484223B1 (cs)
JP (1) JP2594855B2 (cs)
CN (1) CN1030075C (cs)
AT (1) ATE119518T1 (cs)
AU (1) AU641290B2 (cs)
BG (1) BG61924B2 (cs)
BR (1) BR9104711A (cs)
CA (1) CA2054473C (cs)
CZ (1) CZ282036B6 (cs)
DE (1) DE69107959T2 (cs)
DK (1) DK0484223T3 (cs)
ES (1) ES2069854T3 (cs)
FI (2) FI110511B (cs)
GE (1) GEP19981035B (cs)
GR (1) GR3015335T3 (cs)
HR (1) HRP920979B1 (cs)
HU (2) HU215051B (cs)
IE (1) IE69330B1 (cs)
IL (1) IL99811A (cs)
NO (1) NO175898C (cs)
NZ (1) NZ240403A (cs)
PT (1) PT99381B (cs)
SI (1) SI9111731B (cs)
SK (1) SK281720B6 (cs)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL99811A (en) * 1990-10-30 1996-03-31 Roussel Uclaf 3-cycloalkyl-propanamides their tautomer forms and their salts preparation process and compositions containing them
IL102790A (en) * 1991-09-17 1996-01-31 Roussel Uclaf 3-Cycloalkyl-prop-2- enamide derivatives
DE59203828D1 (de) * 1991-10-23 1995-11-02 Hoechst Ag N-phenyl-2-cyano-3-hydroxycrotonsäureamidderivate und deren Verwendung als Arzneimittel mit immunmodulatorischer Eigenschaft.
GB9200275D0 (en) * 1992-01-08 1992-02-26 Roussel Lab Ltd Chemical compounds
GB9300083D0 (en) * 1993-01-05 1993-03-03 Roussel Lab Ltd Chemical compounds
TW314467B (cs) * 1993-03-31 1997-09-01 Hoechst Ag
GB9313365D0 (en) * 1993-06-29 1993-08-11 Roussel Lab Ltd Chemical compounds
US5519042A (en) * 1994-01-13 1996-05-21 Hoechst Aktiengesellschaft Method of treating hyperproliferative vascular disease
FR2727628B1 (fr) * 1994-12-02 1997-01-10 Roussel Uclaf Application des derives de 3-cycloalkyl-propanamide a titre de medicaments analgesiques
GB9520092D0 (en) * 1995-10-02 1995-12-06 Hoechst Roussel Ltd Chemical compounds
DE19539638A1 (de) * 1995-10-25 1997-04-30 Hoechst Ag Die Verwendung von Isoxazol- und Crotonsäureamidderivaten zur Behandlung von Krebserkrankungen
DE19547648A1 (de) * 1995-12-20 1997-06-26 Hoechst Ag Zubereitung, enthaltend High Density Lipoproteine und Crotonsäureamidderivate
US5981536A (en) * 1996-07-31 1999-11-09 Hoechst Aktiengesellschaft Use of xanthine derivatives for the modulation of apoptosis
US5856330A (en) * 1996-07-31 1999-01-05 Hoechst Aktiengesellschaft Use of xanthine derivatives for the inhibition of dephosphorylation of cofilin
US6011051A (en) * 1996-07-31 2000-01-04 Hoechst Aktiengesellschaft Use of isoxazole and crotonamide derivatives for the modulation of apoptosis
US6355678B1 (en) 1998-06-29 2002-03-12 Parker Hughes Institute Inhibitors of the EGF-receptor tyrosine kinase and methods for their use
AU731777B2 (en) 1998-11-30 2001-04-05 Nihon Nohyaku Co., Ltd. Aniline derivative and process for producing the same
US6566395B1 (en) 1999-05-25 2003-05-20 Biomedicines, Inc. Methods of treating proliferative disorders
US20160287549A1 (en) 2013-11-22 2016-10-06 Genzyme Corporation Novel methods for treating neurodegenerative diseases

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR831461A (fr) * 1937-01-09 1938-09-05 Ste Ind Chim Bale Nouveaux produits de condensation
US3116312A (en) * 1960-03-31 1963-12-31 American Cyanamid Co Substituted-2-cyanoacetanilides
NL6911567A (cs) * 1968-08-08 1970-02-10
DE2307156A1 (de) * 1973-02-14 1974-08-22 Henkel & Cie Gmbh N,n-disubstituierte alpha-cyanacrylsaeureamide und deren herstellung
DE2555789A1 (de) * 1975-12-11 1977-07-07 Hoechst Ag Neue cyanessigsaeureanilid-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel
US4393217A (en) * 1981-01-12 1983-07-12 American Cyanamid Company Substituted phenyl-5-aminopyrazoles
US4946867A (en) * 1987-09-07 1990-08-07 Sumitomo Chemical Company, Limited Cyanoacetamide derivative, and plant disease protectant comprising the same as an active ingredient
US4888357A (en) * 1988-01-26 1989-12-19 Bristol-Myers Company Antiarthritic β-cycloalkyl-β-oxopropionitriles
US5034410A (en) * 1989-10-11 1991-07-23 Syntex (U.S.A.) Inc. Anthelmintically active benzenepropanamide derivatives
IL99811A (en) * 1990-10-30 1996-03-31 Roussel Uclaf 3-cycloalkyl-propanamides their tautomer forms and their salts preparation process and compositions containing them

Also Published As

Publication number Publication date
HU913394D0 (en) 1992-01-28
DE69107959D1 (de) 1995-04-13
IL99811A0 (en) 1992-08-18
CS327391A3 (en) 1992-05-13
NO175898B (no) 1994-09-19
JPH04288048A (ja) 1992-10-13
HU211614A9 (en) 1995-12-28
DE69107959T2 (de) 1995-11-16
US5240960B1 (en) 1995-05-02
FI915091A7 (fi) 1992-05-01
JP2594855B2 (ja) 1997-03-26
NO914232L (no) 1992-05-04
US5384423A (en) 1995-01-24
PT99381A (pt) 1992-09-30
NO914232D0 (no) 1991-10-29
GR3015335T3 (en) 1995-06-30
ES2069854T3 (es) 1995-05-16
EP0484223A2 (fr) 1992-05-06
HUT59661A (en) 1992-06-29
FI915091A0 (fi) 1991-10-29
AU641290B2 (en) 1993-09-16
NO175898C (no) 1994-12-28
NZ240403A (en) 1994-10-26
CN1064482A (zh) 1992-09-16
DK0484223T3 (da) 1995-06-19
GEP19981035B (en) 1998-03-26
EP0484223A3 (en) 1993-04-07
IE69330B1 (en) 1996-09-04
CN1030075C (zh) 1995-10-18
EP0484223B1 (fr) 1995-03-08
IL99811A (en) 1996-03-31
US5240960A (en) 1993-08-31
CA2054473C (fr) 2003-07-29
FI119986B (fi) 2009-05-29
HU215051B (hu) 1998-12-28
SK281720B6 (sk) 2001-07-10
BR9104711A (pt) 1992-06-16
HRP920979B1 (en) 2000-06-30
AU8686991A (en) 1992-05-07
FI20021681A7 (fi) 2002-09-20
CA2054473A1 (fr) 1992-05-01
ATE119518T1 (de) 1995-03-15
CZ282036B6 (cs) 1997-04-16
SI9111731B (en) 2001-02-28
PT99381B (pt) 1999-04-30
SI9111731A (en) 1997-12-31
IE913768A1 (en) 1992-05-22
FI110511B (fi) 2003-02-14
HRP920979A2 (en) 1997-12-31

Similar Documents

Publication Publication Date Title
BG61924B2 (bg) Нови 3-циклоалкилпропанамиди,техни тавтомерни форми,техни соли,метод за получаването им,приложението им като лекарствени средства и съдържащите ги състави
RU2112772C1 (ru) Производные 2-циано-3-гидроксиенамидов, способы их получения, фармацевтическая композиция на их основе
CZ85293A3 (en) Process for preparing pyrimidine compounds
JPH06128230A (ja) ２−ホルミルピリジンチオセミカルバゾン抗腫瘍剤
JP3642797B2 (ja) フェニルカルボキサミドイソオキサゾールの新誘導体及びそれらの塩類、それらの製造法及びこの製造法の新規な中間体、それらの薬剤としての用途並びにそれらを含有する製薬組成物
JP4445602B2 (ja) ピリジン−２，３−ジカルボキシレート化合物の製造方法およびその中間体
AU663017B2 (en) Chemical compounds
HU210164B (en) Process for preparing 3-cycloalkyl-prop-2-enamide derivatives and pharmaceutical compn. contg. them
JPH10120666A (ja) グアニジン誘導体の製造方法
JPH05262734A (ja) ５−置換された２−クロロピリジン類の製造方法
EP0006628B1 (en) Substituted dihydropyridine ureas, process for preparing the same and pharmaceutical compositions containing them
RU2073667C1 (ru) 3-циклоалкил-пропанамиды, проявляющие противовоспалительную и иммуноподавляющую активность, способ их получения, цианамид и фармацевтическая композиция
DE2756771A1 (de) Verfahren zur herstellung von neuen substituierten 5-amino-2-pyridincarbonsaeure-verbindungen
MIYANO et al. N-Alkylation of Aromatic Amines by Means of Alcohol. III. New Syntheses of N-Pyridylmethyleneaniline and Related Compounds
RU2339619C2 (ru) Способ получения никотинальдегидов
RU2072987C1 (ru) Производные 3-циклоалкилпропен-2-амида или их аддитивные соли с минеральными или органическими основаниями, способ их получения и фармацевтическая композиция, обладающая противовоспалительной активностью
JPH0710852B2 (ja) イソオキサゾリジン誘導体
SU371245A1 (ru) Способ получения дипропаргилового эфира 1-окси-2, 2, 2-трихлорэтилфосфоновой кислоты
SU1299504A3 (ru) Способ получени производных 3-хлор-1-формил-4-фенилпирролов
EP1756029A1 (fr) Nouveaux composes, leur preparation et leur utilisation pour la synthese regiospecifique d'heterocycles a groupement perfluoro-alkyle.
HK1024238A (en) Process and intermediates for the manufacture of pyridine-2,3-dicarboxylate compounds
FR2649108A1 (fr) Nouvelles pteridines, procedes de preparation et medicaments les contenant